2011 February 17 | Ergün Sahin1,2, Simona Colla1,2, Marc Liesa3,*, Javid Moslehi2,4, Florian L. Müller1,2, Mira Guo5, Marcus Cooper6, Darrell Kotton3, Attila J. Fabian7, Carl Walkey8, Richard S. Maser1,2, Giovanni Tonon1,2, Friedrich Foerster1,2, Robert Xiong1, Y. Alan Wang1, Sachet A. Shukla1, Mariela Jaskelioff1,2, Eric S. Martin1,2, Timothy P. Heffernan1, Alexei Protopopov1, Elena Ivanova1, John E. Mahoney1, Maria Kost-Alimova1, Samuel R. Perry1, Roderick Bronson9, Ronglih Liao4, Richard Mulligan7, Orian S. Shirihai3, Lynda Chin1,2, and Ronald A. DePinho1,2,4,7
Telomere dysfunction leads to metabolic and mitochondrial compromise. The study shows that telomere dysfunction activates p53, which represses PGC-1α and PGC-1β, leading to impaired mitochondrial biogenesis, reduced gluconeogenesis, cardiomyopathy, and increased reactive oxygen species (ROS). This dysfunction is associated with organ failure and reduced organismal fitness. Telomere dysfunction was shown to decrease mitochondrial DNA content and impair mitochondrial function in mice. The study also demonstrates that p53 deficiency can restore PGC network expression, mitochondrial respiration, and cardiac function. Telomere dysfunction represses PGC-1α and PGC-1β, which are critical for mitochondrial biology and cellular metabolism. The study further shows that p53 directly represses PGC-1α and PGC-1β promoters, linking telomere dysfunction to mitochondrial and metabolic compromise. The findings suggest that telomere dysfunction contributes to age-related pathologies by impairing mitochondrial function and PGC activity. The study also highlights the importance of PGC-1α and PGC-1β in maintaining mitochondrial function and metabolic homeostasis. Overall, the study provides evidence that telomere dysfunction leads to mitochondrial and metabolic compromise, contributing to organ failure and aging.Telomere dysfunction leads to metabolic and mitochondrial compromise. The study shows that telomere dysfunction activates p53, which represses PGC-1α and PGC-1β, leading to impaired mitochondrial biogenesis, reduced gluconeogenesis, cardiomyopathy, and increased reactive oxygen species (ROS). This dysfunction is associated with organ failure and reduced organismal fitness. Telomere dysfunction was shown to decrease mitochondrial DNA content and impair mitochondrial function in mice. The study also demonstrates that p53 deficiency can restore PGC network expression, mitochondrial respiration, and cardiac function. Telomere dysfunction represses PGC-1α and PGC-1β, which are critical for mitochondrial biology and cellular metabolism. The study further shows that p53 directly represses PGC-1α and PGC-1β promoters, linking telomere dysfunction to mitochondrial and metabolic compromise. The findings suggest that telomere dysfunction contributes to age-related pathologies by impairing mitochondrial function and PGC activity. The study also highlights the importance of PGC-1α and PGC-1β in maintaining mitochondrial function and metabolic homeostasis. Overall, the study provides evidence that telomere dysfunction leads to mitochondrial and metabolic compromise, contributing to organ failure and aging.